PAM
AZN icon

Panagora Asset Management’s AstraZeneca AZN Stock Holding History

Panagora Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,014
Closed -$541K – 1211
2023
Q4 		$541K Sell
4,014
-10,990
-73% -$1.43M ﹤0.01% 971
2023
Q3 		$2.03M Buy
15,004
+964
+7% +$132K 0.01% 514
2023
Q2 		$2.01M Buy
14,040
+8,225
+141% +$1.21M 0.01% 537
2023
Q1 		$807K Buy
+5,815
New +$782K 0.01% 921
2022
Q3 		– Sell
-5,377
Closed -$710K – 1440
2022
Q2 		$710K Sell
5,377
-601
-10% -$78.9K ﹤0.01% 1028
2022
Q1 		$793K Buy
5,978
+2,124
+55% +$255K ﹤0.01% 1032
2021
Q4 		$449K Sell
3,854
-13,397
-78% -$1.58M ﹤0.01% 1257
2021
Q3 		$2.07M Buy
17,251
+617
+4% +$71.8K 0.01% 674
2021
Q2 		$1.99M Sell
16,634
-2,681
-14% -$294K 0.01% 706
2021
Q1 		$1.92M Sell
19,315
-18,605
-49% -$1.87M 0.01% 754
2020
Q4 		$3.79M Sell
37,920
-12,888
-25% -$1.37M 0.02% 497
2020
Q3 		$5.57M Sell
50,808
-423
-0.8% -$47K 0.03% 374
2020
Q2 		$5.42M Buy
51,231
+19,686
+62% +$2.03M 0.03% 377
2020
Q1 		$2.82M Buy
31,545
+17,397
+123% +$1.64M 0.02% 496
2019
Q4 		$1.41M Sell
14,148
-1,636
-10% -$154K 0.01% 919
2019
Q3 		$1.41M Buy
15,784
+6,043
+62% +$524K 0.01% 888
2019
Q2 		$804K Buy
9,741
+931
+11% +$73K ﹤0.01% 1242
2019
Q1 		$712K Sell
8,810
-118
-1% -$9.3K ﹤0.01% 1265
2018
Q4 		$678K Buy
8,928
+2,027
+29% +$158K ﹤0.01% 1234
2018
Q3 		$546K Buy
+6,901
New +$522K ﹤0.01% 1349
2017
Q2 		– Sell
-4,513
Closed -$281K – 2591
2017
Q1 		$281K Hold
4,513
– – ﹤0.01% 1541
2016
Q4 		$247K Sell
4,513
-2,863
-39% -$163K ﹤0.01% 1675
2016
Q3 		$485K Buy
+7,376
New +$482K ﹤0.01% 1462
2014
Q4 		– Sell
-2,740
Closed -$196K – 2288
2014
Q3 		$196K Sell
2,740
-4,425
-62% -$324K ﹤0.01% 1646
2014
Q2 		$532K Buy
+7,165
New +$518K ﹤0.01% 1353

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Panagora Asset Management's AZN Position: Q1 2024 in Review

Panagora Asset Management sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 4,014 shares — an estimated $541K sold.

Panagora Asset Management first reported a position in AZN in Q2 2014 and held it in 25 quarters. The position peaked at $5.57M in Q3 2020. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Panagora Asset Management reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Panagora Asset Management sold 4,014 AstraZeneca shares in Q1 2024, an estimated $541K.
  • Panagora Asset Management first reported a position in AstraZeneca in Q2 2014 and held it in 25 quarters.
  • Panagora Asset Management's AstraZeneca position peaked at $5.57M in Q3 2020.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Panagora Asset Management's 13F filing for Q1 2024, filed 7 May 2024.